Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Taylor

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomesMartin Reck, Tudor-Eliade Ciuleanu, Manuel Cobo, et al.
British Journal of Cancer|September 7, 2021
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary PathologistsColin R Lindsay, Emily C Shaw, David A Moore, et al.
Lung Cancer (Amsterdam, Netherlands)|January 30, 2022
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancerJianhua Chang, Yi-Long Wu, Shun Lu, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2019
Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer ConsortiumDaniel Shepshelovich, Wei Xu, Lin Lu, et al.
Research Square|August 20, 2025
Genes associated with genetic and rare lung diseases and the risk of lung cancerAlbert Rosenberger, Heike Bickeböller, David C Christiani, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2020
The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patientsMei Jiang, Aline F Fares, Daniel Shepshelovich, et al.
European Journal of Medical Research|February 1, 2022
Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancerAlbert Rosenberger, Nils Muttray, Rayjean J Hung, et al.
Carcinogenesis|August 1, 2025
Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer ConsortiumMei Dong, Abhinav Thakral, Karl Smith- Byrne, et al.
Human Molecular Genetics|May 9, 2025
Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility lociJinyoung Byun, Younghun Han, Jiyeon Choi, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomesMartin Reck, Tudor-Eliade Ciuleanu, Manuel Cobo, et al.
British Journal of Cancer|September 7, 2021
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary PathologistsColin R Lindsay, Emily C Shaw, David A Moore, et al.
Lung Cancer (Amsterdam, Netherlands)|January 30, 2022
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancerJianhua Chang, Yi-Long Wu, Shun Lu, et al.
Human Molecular Genetics|July 20, 2023
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer riskJennifer Luyapan, Yohan Bossé, Zhonglin Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2019
Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer ConsortiumDaniel Shepshelovich, Wei Xu, Lin Lu, et al.
Research Square|August 20, 2025
Genes associated with genetic and rare lung diseases and the risk of lung cancerAlbert Rosenberger, Heike Bickeböller, David C Christiani, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2020
The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patientsMei Jiang, Aline F Fares, Daniel Shepshelovich, et al.
European Journal of Medical Research|February 1, 2022
Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancerAlbert Rosenberger, Nils Muttray, Rayjean J Hung, et al.
Carcinogenesis|August 1, 2025
Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer ConsortiumMei Dong, Abhinav Thakral, Karl Smith- Byrne, et al.
Human Molecular Genetics|May 9, 2025
Genome-wide association study for lung cancer in 6531 African Americans reveals new susceptibility lociJinyoung Byun, Younghun Han, Jiyeon Choi, et al.
Pageof 9